+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials



Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials



Annals of Internal Medicine 113(4): 299-307



To determine whether corticosteroids affect short-term mortality from alcoholic hepatitis. Studies published from 1966 to 1989 were identified through a MEDLINE computer search and an extensive manual search of the bibliographies of identified articles. We found 11 randomized studies (10 of which were placebo controlled) that assessed mortality in hospitalized patients diagnosed with acute alcoholic hepatitis and treated with corticosteroids. Two critical appraisers independently evaluated trial quality and abstracted quantitative data on clinical characteristics of the populations, interventions, and all-cause mortality. Overall, the protective efficacy (or percent reduction in mortality) of corticosteroids was 37% (95% CI, 20% to 50%). Protective efficacy was higher among trials with higher quality scores and trials that excluded subjects with active gastrointestinal bleeding. In subjects with hepatic encephalopathy, protective efficacy was 34% overall (CI, 15% to 48%). It was also higher among trials with higher quality scores and trials excluding subjects with acute gastrointestinal bleeding, but was not present among trials with lower quality scores or trials that did not exclude subjects with acute gastrointestinal bleeding. In subjects without hepatic encephalopathy, corticosteroids had no protective effect, and this lack of efficacy was consistent across all trial subgroups. These results suggest that corticosteroids reduce short-term mortality in patients with acute alcoholic hepatitis who have hepatic encephalopathy, that the protective effect depends on the exclusion criterion of acute gastrointestinal bleeding and is influenced by trial quality, and that corticosteroids are of no benefit in patients without hepatic encephalopathy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039856907

Download citation: RISBibTeXText

PMID: 2142869


Related references

Corticosteroids reduce mortality from alcoholic hepatitis a meta analysis of the randomized trials. Hepatology 10(4): 580, 1989

Corticosteroids reduce mortality from alcoholic hepatitis in patients without encephalopathy a meta analysis of the randomized trials rcts including french trials. Hepatology 14(4 PART 2): 234A, 1991

Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver International 36(5): 721-728, 2015

Corticosteroids decrease short term mortality in patients with severe alcoholic hepatitis Individual data meta-analysis of the last three randomized placebo controlled double blind trials. Hepatology 32(4 Pt 2): 419A, October, 2000

Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials. Journal of Clinical Gastroenterology 50(10): 871-881, 2016

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. Journal of Hepatology 36(4): 480-487, 2002

Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data. Gastroenterology, 2018

Corticosteroids efficacy in severe alcoholic hepatitis Retrospective analysis of individual data from the American and French randomized controlled trials. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A972, April, 2000

The equity impact of community women's groups to reduce neonatal mortality: a meta-analysis of four cluster randomized trials. International Journal of Epidemiology, 2017

Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis. Critical Care Medicine 42(6): 1442-1454, 2014

Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials. Anesthesia and Analgesia 118(2): 346-357, 2014

Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Critical Care 19(): 10-10, 2016

Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. American Journal of Gastroenterology 103(1): 104-110, 2007

Effects of corticosteroids in alcoholic hepatitis results of a meta analysis. Gastroenterology 100(5 PART 2): A819, 1991

Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials. Chest 145(6): 1286-1297, 2014